April 05, 2011
Ortho-McNeil-Janssen Pharmaceuticals Inc. lost a bid to toss a suit Tuesday accusing the drugmaker of marking five medical supplies with expired patents, despite the heightened pleading standards for false marking whistleblowers set by a recent ruling of the Federal Circuit.